H.R. 255 would direct the National Science Foundation (NSF) to encourage its entrepreneurial programs to recruit and support women to develop commercial applications of their laboratory research. CBO estimates that implementing the legislation would have no cost because it assigns no specific tasks to the NSF.
Enacting H.R. 255 would not affect direct spending or revenues; therefore, pay-as-you-go procedures do not apply.
CBO estimates that enacting H.R. 255 would not increase net direct spending or on-budget deficits in any of the four consecutive 10-year periods beginning in 2028.
H.R. 255 contains no intergovernmental or private-sector mandates as defined in the Unfunded Mandates Reform Act and would impose no costs on state, local, or tribal governments.
